IP Library Granted Patent US 8,415,162
Granted Patent B2
US 8,415,162 · App. 13/566,045 · Granted Apr 9, 2013

Measuring levels of a metabolite

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,415,162
App. No.
13/566,045
Granted
Apr 9, 2013
Kind
B2
Abstract

Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.

Claims (32)

1. A method for determining an amount of a vitamin D metabolite in a test sample, the method comprising:

(a) providing a set of calibrator samples, each calibrator sample comprising a different amount of a first isotopically-labeled standard in a biological matrix,

(b) providing to each calibrator sample a selected constant amount of a second isotopically labeled standard, the first and second isotopically labeled standards having distinct isotope content, and wherein the first and second isotopically labeled standards are isotopically-labeled vitamin D metabolite derivatives;

(c) subjecting the calibrator samples comprising the first and second isotopically-labeled standards to mass spectrometry to determine signal intensities corresponding to the first and second isotopically-labeled standards;

(d) generating a calibration curve based on ratios of the determined signal intensities of the first and second isotopically-labeled standards as a function of the amount of the first isotopically-labeled standard in the calibrator samples;

(e) contacting a test sample with the selected constant amount of the second isotopically-labeled standard;

(f) subjecting the test sample comprising the second isotopically-labeled standard to mass spectrometry to determine signal intensities corresponding to the second isotopically labeled standard and the vitamin D metabolite, and

(g) using the calibration curve and the determined signal intensities corresponding to the second isotopically labeled standard and the vitamin D metabolite to determine the amount of the vitamin D metabolite in the test sample.

2. The method of claim 1 , wherein the vitamin D metabolite is selected from 25-hydroxyvitamin D3, 1-hydroxyvitamin D3, 1, 25-dihydroxyvitamin D3, 25-hydroxyvitamin D2, 1α-hydroxyvitamin D2, and 24-hydroxyvitamin D2.

3. The method of claim 1 , wherein the vitamin D metabolite is a vitamin D3 metabolite and the first isotopically-labeled standard is selected from isotopically labeled 1, 25-dihydroxyvitamin D3 and isotopically-labeled 25-hydroxyvitamin-D3.

4. The method of claim 1 , wherein the first isotopically-labeled standard is labeled with 2H, 13 C, 15 N, 18 O, or a combination thereof.

5. The method of claim 4 , wherein the first isotopically-labeled standard is selected from labeled 1α,25-dihydroxyvitamin D3, d 6 -labeled 25-hydroxyvitamin-D3, d 3 -labeled 1, 25-dihydroxyvitamin D3 and d 3 -labeled 25-hydroxyvitamin-D3.

6. The method of claim 5 , wherein the first isotopically-labeled standard is 25-hydroxyvitamin-D3 (26,26,26,27,27,27-d 6 ).

7. The method of claim 4 , wherein the first isotopically-labeled standard is 25-hydroxyvitamin-D2 (26,26,26,27,27,27-d 6 ).

8. The method of claim 1 , wherein the vitamin D metabolite is a vitamin D3 metabolite and the second isotopically-labeled standard is selected from isotopically labeled 1, 25-dihydroxyvitamin D3 and isotopically-labeled 25-hydroxyvitamin-D3.

9. The method of claim 1 , wherein the second isotopically-labeled standard is labeled with deuterium.

10. The method of claim 9 , wherein the second isotopically-labeled standard is selected from d 6 -labeled 1, 25-dihydroxyvitamin D3, d 6 -labeled 25-hydroxyvitamin-D3, d 3 -labeled 1, 25-dihydroxyvitamin D3 and d 3 -labeled 25-hydroxyvitamin-D3.

11. The method of claim 10 , wherein the second isotopically-labeled standard is 25-hydroxyvitamin-D3 (6,19,19-d 3 ).

12. The method of claim 1 , wherein the vitamin D metabolite is a vitamin D2 metabolite.

13. The method of claim 12 , wherein the vitamin D metabolite is a vitamin D2 metabolite and the first isotopically-labeled standard is selected from 1,25-dihydroxyvitamin D2 and 25-hydroxyvitamin-D2.

14. The method of claim 12 , wherein the vitamin D metabolite is a vitamin D2 metabolite and the second isotopically-labeled standard is selected from 1,25-dihydroxyvitamin D2 and 25-hydroxyvitamin-D2.

15. The method of claim 14 , wherein the second isotopically-labeled standard is 25-hydroxyvitamin-D2 (6,19,19-d 3 ).

16. The method of claim 1 , wherein the mass spectrometry comprises a technique selected from LC-MS and LC-MS/MS.

17. The method of claim 1 , wherein the test sample is a biological sample.

18. The method of claim 14 , wherein the biological sample is selected from the group consisting of blood, serum, plasma, saliva, and urine.

19. The method of claim 18 , wherein the blood is provided dried on a paper matrix.

20. The method of claim 1 , wherein first and second isotopically-labeled standards each comprise a different number of isotopic labels comprising the same isotope.

21. A kit for determining an amount of an vitamin D metabolite in a test sample, comprising:

an isotopically labeled calibrator standard, and

an isotopically labeled internal standard,

wherein the first and second isotopically labeled standards are isotopically-labeled vitamin D metabolite derivatives; and

wherein the calibrator and internal standards have distinct isotope content.

Assignments (3)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 066881/0340 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME TO READ PERKINELMER HEALTH SCIENCES, INC. (CHANGED FROM PERKIN ELMER LIFE SCIENCES) DOCUMENT ID NO. 502152825 PREVIOUSLY RECORDED ON REEL 029245 FRAME 0006. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 6, 2012
From: CERDA, BLAS; CHERKASSKIY, ALEX
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 029819/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2012
From: CERDA, BLAS; CHERKASSKIY, ALEX
To: PERKIN ELMER LIFE SCIENCES
Reel/Frame 029245/0006 →